| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1029671230 |
| P356 | DOI | 10.1186/S12985-015-0330-4 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12985-015-0330-4 |
| P932 | PMC publication ID | 4501209 |
| P698 | PubMed publication ID | 26169596 |
| P5875 | ResearchGate publication ID | 280058645 |
| P50 | author | Johan Neyts | Q29460378 |
| Pieter Leyssen | Q29460394 | ||
| Céline Lacroix | Q60642597 | ||
| Fabrizio Angius | Q80765543 | ||
| Raffaello Pompei | Q114401482 | ||
| ??? | Q64785685 | ||
| Romano Silvestri | Q42718323 | ||
| P2093 | author name string | Samuela Laconi | |
| P2860 | cites work | An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus | Q27684137 |
| A novel benzonitrile analogue inhibits rhinovirus replication | Q27690771 | ||
| In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity | Q28343180 | ||
| Combating enterovirus replication: State-of-the-art on antiviral research | Q29038131 | ||
| Empirical scoring functions for advanced protein-ligand docking with PLANTS. | Q51857293 | ||
| Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection | Q30433145 | ||
| VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds | Q30449577 | ||
| Intranasal pirodavir (R77,975) treatment of rhinovirus colds | Q30452921 | ||
| Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation | Q34840845 | ||
| The role of viruses in acute exacerbations of asthma | Q37761773 | ||
| Study of the biological activity of novel synthetic compounds with antiviral properties against human rhinoviruses. | Q39552394 | ||
| Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds | Q40163296 | ||
| Isoxazoles with antipicornavirus activity | Q42204966 | ||
| Synthesis of new compounds with promising antiviral properties against group A and B Human Rhinoviruses | Q42209472 | ||
| FDA panel rejects common cold treatment | Q44026717 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 106 | |
| P577 | publication date | 2015-07-14 | |
| P1433 | published in | Virology Journal | Q7934868 |
| P1476 | title | In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses | |
| P478 | volume | 12 |
| Q90158385 | A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68 |
| Q92656973 | A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses |
| Q60309721 | Anti-Human Rhinovirus 1B Activity of Dexamethasone viaGCR-Dependent Autophagy Activation |
| Q64450546 | Antiviral therapeutic approaches for human rhinovirus infections |
| Q92964237 | Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site |
Search more.